Safety profile of iron polymaltose infusions.

Published in: Hospital practice (1995) (2019)

Iron polymaltose has a low rate of adverse drug reactions; yet, serious side-effects such as hypotension may occur. Perturbations in hemodynamics within the first 20 min suggest close monitoring is necessary in the initial stages of infusion.

Keyphrases

adverse drug
iron deficiency
electronic health record
low dose
emergency department
drug induced